Agios Pharmaceuticals, Inc. (AGIO)
28.15
-0.02
(-0.07%)
USD |
NASDAQ |
May 18, 12:03
Agios Pharmaceuticals Research and Development Expense (Quarterly) : 79.78M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 471.10M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Apellis Pharmaceuticals, Inc. | 76.96M |
| Amgen, Inc. | 1.719B |
| MannKind Corp. | 17.23M |